Fatal Yellow Fever in Travelers to Brazil, 2018

Guardado en:
Detalles Bibliográficos
Publicado en:MMWR. Morbidity and Mortality Weekly Report vol. 67, no. 11 (Mar 23, 2018), p. 340
Autor principal: Hamer, Davidson H, MD
Otros Autores: Angelo, Kristina, DO, Caumes, Eric, MD, van Genderen, Perry J J, MD, PhD, Florescu, Simin A, MD, PhD, Popescu, Corneliu P, MD, Perret, Cecilia, MD, McBride, Angela, BMBS, Checkley, Anna, MBChB, DPhil, Ryan, Jenny, MBBS, Cetron, Martin, MD, Schlagenhauf, Patricia, PhD
Publicado:
U.S. Center for Disease Control
Materias:
Acceso en línea:Citation/Abstract
Full Text
Full Text - PDF
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
Descripción
Resumen:Yellow fever virus is a mosquito-borne flavivirus that causes yellow fever, an acute infectious disease that occurs in South America and sub-Saharan Africa. Most patients with yellow fever are asymptomatic, but among the 15% who develop severe illness, the case fatality rate is 20%-60%. Effective live-attenuated virus vaccines are available that protect against yellow fever. An outbreak of yellow fever began in Brazil in December 2016; since July 2017, cases in both humans and nonhuman primates have been reported from the states of Sao Paulo, Minas Gerais, and Rio de Janeiro, including cases occurring near large urban centers in these states. Yellow fever is a potentially fatal illness that is preventable by vaccination. Yellow fever vaccination is recommended for all eligible persons aged ≥9 months, traveling to many areas in Brazil, including the states of Sao Paulo and Rio de Janeiro (especially Ilha Grande).
ISSN:0149-2195
1545-861X
0091-0031
Fuente:Healthcare Administration Database